2023 AANEM CME Symposium - Navigating the Complexities of Recognizing, Diagnosing and Treating Transthyretin Amyloid Polyneuropathy (ATTR-PN)

HAZLET, N.J. - PrZen -- In this program, ATTR-PN experts (chair Dr. Sami Khella, and faculty members Dr. Morie Gertz and Dr. Amanda Peltier) will describe the signs, symptoms, hereditability, and other factors that indicate possible ATTR-PN. The diagnostic process will be explained, and data with currently available and emerging therapies will be discussed.

Click here for more information

CHAIR

Sami Khella, MD
Professor and Chief of Neurology
Penn Presbyterian Medical Center
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

FACULTY

Morie Gertz, MD, MACP
Chair Emeritus, Department of Internal Medicine
Ronald Seidler Jr. Professor of Medicine
Mayo Distinguished Clinician
Mayo Clinic
Rochester, Minnesota

Amanda Peltier, MD, MS
Professor of Neurology and Medicine
Chief, Division of Neuromuscular Disorders
Associate Vice Chair of Faculty Affairs
Vanderbilt University Medical Center
Nashville, Tennessee

This educational activity is intended for clinicians managing patients with ATTR-PN.

Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #AANEM2023 #ATTR-PN #neurology #cme